Phase I Trial of Capecitabine and Weekly Irinotecan in Combination With Radiotherapy for Neoadjuvant Therapy of Rectal Cancer
Journal of Clinical Oncology
Vol 23, No 7 (March 1), 2005: pp. 1350-1357
Ralf-Dieter Hofheinz, Bolko von Gerstenberg-Helldorf, Frederik Wenz, Ulrike Gnad, Uta Kraus-Tiefenbacher, Albrecht Müldner, Rüdiger Hehlmann, Stefan Post, Andreas Hochhaus, Frank Willeke
DOI: 10.1200/JCO.2005.04.171
Go to journal article.
Journal Article: Capecitabine, Irinotecan, and Radiation for Rectal Cancer
Cancer Research March 2005
From Donna Myers, former About.com Guide
Updated: August 7, 2005
About.com Health's Disease and Condition content is reviewed by the Medical Review Board
See More About:
Related Articles
- Phase I Trial of Capecitabine and Weekly Irinotecan in Combination With Rad...
- Ovarian Cancer Clinical Trials and Research Options
- Clinical Trials - Learn the Basics of Clinical Trials
- Types and Phases of Clinical Trials - Overview of Types and Phases of Clini...
- What are the Steps to Getting FDA Approval for a New Diabetes Therapy?
Related Searches journal of clinical oncology cancer journal r 252 hofheinz gerstenberg capecitabine
Explore Colon Cancer
- About.com
- Health
- Colon Cancer
- Basics
- Research Articles
- Journal Article Abstracts
- Journal Articles from 2005
- Phase I Trial of Capecitabine and Weekly Irinotecan in Combination With Radiotherapy for Neoadjuvant Therapy of Rectal Cancer
